NOVO NORDISK: OVERALL DEMAND WILL CONTINUE TO EXCEED SUPPLY WHICH MEANS THAT SOME PATIENTS MAY STILL HAVE DIFFICULTY FILLING WEGOVY® PRESCRIPTIONS.